input,__expected,__metric,__threshold
What is the her2-neu gene?,,latency,8000
What is the her2-neu gene?,"The HER-2/neu gene is a member of the erbB-like oncogene family and is related to, but distinct from, the epidermal growth factor receptor (EGFR). It encodes a protein that is involved in cellular signaling and has been shown to be amplified in human breast cancer cell lines. The gene is significant in the context of breast cancer, as its amplification has been linked to prognosis and disease outcomes.",factuality,
Summarize this article in plain language,,latency,8000
Summarize this article in plain language,"The article discusses the HER-2/neu oncogene, which is related to a group of genes involved in cancer. Researchers studied this gene in 189 cases of breast cancer and found that it was often amplified, meaning there were higher amounts of it in the tumors. Specifically, in about 30% of the cases, the HER-2/neu gene was found to be present in 2 to over 20 times higher than normal. This means that the HER-2/neu gene could be used to predict if breast cancer will get significantly worse.",factuality,
What are the most important takeaways from this article?,,latency,8000
What are the most important takeaways from this article?,"The most important takeaways from the article are:

    Alterations of the HER-2/neu gene were investigated in 189 primary human breast cancers, where it was found to be amplified from 2- to more than 20-fold in 30% of the tumors.
    Amplification of the HER-2/neu gene is a significant predictor of overall survival and time to relapse in breast cancer patients.
    The significance of HER-2/neu amplification as a prognostic factor remains even after accounting for other known prognostic factors.
    HER-2/neu amplification offers greater prognostic value than most currently used prognostic factors, including hormonal-receptor status, particularly in lymph node-positive breast cancer.
    These findings suggest that the HER-2/neu gene may play a crucial role in the biological behavior and pathogenesis of human breast cancer.",factuality,
What is the relationship between the HER-2/neu gene and the epidermal growth factor receptor (EGFR)?,,latency,8000
What is the relationship between the HER-2/neu gene and the epidermal growth factor receptor (EGFR)?,"The HER-2/neu gene is closely related to, but distinct from, the EGFR gene. Both genes belong to the tyrosine kinase family, but HER-2/neu is located on chromosome 17, whereas EGFR is located on chromosome 7.",factuality,
What prognostic significance does the amplification of the HER-2/neu gene have in breast cancer?,,latency,8000
What prognostic significance does the amplification of the HER-2/neu gene have in breast cancer?,"Amplification of the HER-2/neu gene was found to be a significant predictor of both overall survival and time to relapse in breast cancer patients. It remained significant even after adjusting for other known prognostic factors and had greater prognostic value than most currently used factors, including hormonal-receptor status in lymph node-positive disease.",factuality,
What factors were evaluated in the breast cancer study to assess the prognosis of patients?,,latency,8000
What factors were evaluated in the breast cancer study to assess the prognosis of patients?,"The factors evaluated in the study included the size of the primary tumor, stage of disease at diagnosis, hormonal receptor status, age of patient, and the number and status of axillary lymph nodes involved with disease.",factuality,
What was the correlation between HER-2/neu gene amplification and the number of positive lymph nodes in the study?,,latency,8000
What was the correlation between HER-2/neu gene amplification and the number of positive lymph nodes in the study?,"The study found a trend showing a higher incidence of HER-2/neu gene amplification in patients with more than three positive axillary lymph nodes. Specifically, 32% of patients with more than three involved nodes had gene amplification, and this correlation became statistically significant when comparing patients with 0-3 positive nodes versus those with more than 3 positive nodes (P < 0.05).",factuality,
What were the results of the second study on 100 node-positive breast cancer patients regarding HER-2/neu amplification and its correlation with disease parameters?,,latency,8000
What were the results of the second study on 100 node-positive breast cancer patients regarding HER-2/neu amplification and its correlation with disease parameters?,"In the second study, HER-2/neu gene amplification was found in 40% of patients (34/86). The amplification was correlated with the number of involved lymph nodes, estrogen receptor status, and the size of the primary tumor, confirming some of the findings from the initial survey.",factuality,
What was the significance of HER-2/neu gene amplification in predicting relapse and survival in node-positive breast cancer patients?,,latency,8000
What was the significance of HER-2/neu gene amplification in predicting relapse and survival in node-positive breast cancer patients?,"HER-2/neu gene amplification was found to have a strong and statistically significant correlation with both time to disease relapse (P < 0.0001) and overall survival (P = 0.0011). Amplification of the gene was superior to most other prognostic factors, except for the number of positive lymph nodes, in predicting patient outcomes. Notably, patients with more than five copies of the HER-2/neu gene had even shorter disease-free survival times and overall survival compared to those with no amplification.",factuality,
What were the findings regarding the epidermal growth factor receptor (EGFR) gene amplification and rearrangement in breast cancer samples?,,latency,8000
What were the findings regarding the epidermal growth factor receptor (EGFR) gene amplification and rearrangement in breast cancer samples?,"Amplification of the EGFR gene was found in only 2% of the breast cancer samples (4 out of 189 cases), and rearrangement of the EGFR gene was observed in one of these four cases. The incidence of EGFR amplification and rearrangement was too small to perform statistical correlation, and HER-2/neu amplification was 14 times more frequent than EGFR amplification in this study.",factuality,
"What role does HER-2/neu gene amplification play in breast cancer prognosis, and how does it compare to other prognostic factors?",,latency,8000
"What role does HER-2/neu gene amplification play in breast cancer prognosis, and how does it compare to other prognostic factors?","HER-2/neu gene amplification is a significant predictor of overall survival and time to relapse in node-positive breast cancer patients. It retains its prognostic value even after adjusting for other known prognostic factors, such as estrogen and progesterone receptors. In fact, HER-2/neu amplification has greater prognostic value than most currently used factors, including hormone receptor status, and is as important as the number of positive lymph nodes, which is the best-known prognostic factor.",factuality,
"What is the potential significance of HER-2/neu amplification in breast cancer pathogenesis, and how does it relate to other proto-oncogenes like N-myc?",,latency,8000
"What is the potential significance of HER-2/neu amplification in breast cancer pathogenesis, and how does it relate to other proto-oncogenes like N-myc?","HER-2/neu amplification may play a significant role in the pathogenesis of breast cancer, similar to how N-myc amplification is implicated in neuroblastoma. Like N-myc, greater amplification of HER-2/neu is associated with worse prognosis. The amplification of HER-2/neu could potentially provide a growth advantage to cancer cells, similar to how other growth factor receptors affect cancer progression. Identifying the geneâ€™s ligand and developing specific antagonists may offer therapeutic potential.",factuality,